Organism name | Aesculus turbinata |
---|---|
Genus | Aesculus |
Family | Sapindaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Aesculus turbinata |
---|---|
Linked NCBI taxonomy ID | 83375 |
Linked level | species |
Family in NCBI taxonomy | Hippocastanaceae |
---|---|
ID | 910346 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00002473
![]() |
Fraxetin
|
CHEMBL54909
|
C105671
|
32 / 21 / 23 | 6 / 0 | No. 864 | No. 25 |
![]() |
C00002471
![]() |
Esculetin
/ Aesculetin / 6,7-Dihydroxycoumarin |
CHEMBL244743
|
C007628
|
40 / 44 / 32 | 19 / 4 | No. 1030 | No. 25 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00002471 C00002473 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002471 C00002473 | 0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00002471 C00002473 | 4 / 1 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00002471 C00002473 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00002471 C00002473 | 1 / 1 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00002471 C00002473 | 4 / 3 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00002471 C00002473 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00002471 C00002473 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00002471 C00002473 | 1 / 1 |
P29466 | Caspase-1 | C14 | C00002471 C00002473 | 0 / 0 |
P55210 | Caspase-7 | C14 | C00002471 C00002473 | 0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00002471 C00002473 | 0 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00002471 C00002473 | 2 / 2 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002471 C00002473 | 3 / 3 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00002471 C00002473 | 0 / 1 |
O75496 | Geminin | Unclassified protein | C00002471 C00002473 | 0 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00002471 C00002473 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00002471 C00002473 | 0 / 0 |
P06280 | Alpha-galactosidase A | Enzyme | C00002471 | 1 / 1 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00002471 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00002473 | 0 / 0 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00002471 | 1 / 0 |
P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00002471 | 0 / 0 |
P15121 | Aldose reductase | Enzyme | C00002471 | 0 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | C00002473 | 0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00002473 | 0 / 0 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00002471 | 0 / 0 |
O43570 | Carbonic anhydrase 12 | Lyase | C00002473 | 1 / 2 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00002473 | 0 / 0 |
P56817 | Beta-secretase 1 | A1A | C00002471 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00002471 | 0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00002473 | 0 / 1 |
P00918 | Carbonic anhydrase 2 | Lyase | C00002473 | 1 / 2 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00002471 | 1 / 1 |
Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | C00002471 | 0 / 0 |
Q00796 | Sorbitol dehydrogenase | Enzyme | C00002471 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00002471 | 11 / 10 |
Q8N1Q1 | Carbonic anhydrase 13 | Lyase | C00002473 | 0 / 0 |
P43166 | Carbonic anhydrase 7 | Lyase | C00002473 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002471 | 0 / 1 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00002471 | 1 / 1 |
P04062 | Glucosylceramidase | Enzyme | C00002471 | 6 / 4 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00002473 | 0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00002471 | 5 / 1 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00002473 | 0 / 0 |
P34949 | Mannose-6-phosphate isomerase | Enzyme | C00002471 | 1 / 1 |
Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00002471 | 0 / 0 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00002471 | 3 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00002471 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00002473 | 1 / 1 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00002471 | 1 / 0 |
O00255 | Menin | Unclassified protein | C00002473 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00002473 | 1 / 2 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00002471 | 1 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00002471
C00002473
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00002471
C00002473
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00002471
C00002473
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00002471
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00002471
|
1312 | COMT | catechol-O-methyltransferase (EC:2.1.1.6) |
C00002471
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00002471
|
355 | FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | Fas cell surface death receptor |
C00002471
|
356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00002471
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00002471
|
1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00002471
|
637 | BID, FP497 | BH3 interacting domain death agonist |
C00002471
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00002471
|
5601 | MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK | mitogen-activated protein kinase 9 (EC:2.7.11.24) |
C00002471
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00002471
|
1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00002471
|
8797 | TNFRSF10A, APO2, CD261, DR4, TRAILR-1, TRAILR1 | tumor necrosis factor receptor superfamily, member 10a |
C00002471
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00002471
|
7366 | UGT2B15, HLUG4, UDPGT_2B8, UDPGT2B15, UDPGTH3, UGT2B8 | UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17) |
C00002471
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00002473
|
847 | CAT | catalase (EC:1.11.1.6) |
C00002473
|
6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00002473
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#602579 | Congenital disorder of glycosylation, type ib; cdg1b |
P34949
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#301500 | Fabry disease |
P06280
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137800 | Glioma susceptibility 1; glm1 |
O75874
|
#232300 | Glycogen storage disease ii |
P10253
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#278300 | Xanthinuria, type i |
P47989
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
Q16790 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00125 | Fabry disease |
P06280
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00118 | Congenital disorders of glycosylation (CDG) type I |
P34949
(related)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|